Skip to main content

Time in Range

What's new

The tool for people with diabetes to use with their healthcare professionals will launch in early 2020, extending CGM further! Features include fully disposable Bluetooth transmitter, both real-time and blinded options, no fingersticks, and 10-day wear Continue Reading »

The diaTribe team was in Barcelona for the 55th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the conference! Continue Reading »

This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older Continue Reading »

Control-IQ Hybrid Closed Loop on track to launch in the US by the end of 2019 for those ages 14 and older; first system with automatic correction boluses and no fingersticks CGM (Dexcom G6) Continue Reading »

New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2 diabetes Continue Reading »

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2019 Continue Reading »

Tandem control-IQ results

The automated insulin delivery system with Dexcom’s G6 aims to launch in the US by the end of the year for those ages 14+; first system with auto boluses and no fingerstick calibration Continue Reading »

MiniMed 780G, Medtronic, closed loop, artificial pancreas, type 1

This study, now recruiting 350 participants, will examine the safety of the MiniMed 780G Advanced Hybrid Closed Loop System in people with type 1 diabetes (7+ Years) Continue Reading »